Not all clients with CLL require therapy. In spite of all current developments, the iwCLL continue to endorses watchful observation for sufferers with asymptomatic condition.86 This advice is based on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 E